ALFA Finder| Execution period | Valid from 12/05/2026 to 30/09/2035 |
|---|
BSE filing, BSE: 543546. Summary written from the filing by ALFA Finder's alert engine.
Healthy Life Agritec Ltd: key numbers
- Share price
- ₹5.03
- Market cap
- ₹24.96 Cr
- Revenue (annual)
- ₹228.1 Cr
- Net profit (annual)
- ₹4.00 Cr
- P/E (TTM)
- 6.2×Sector 29.0×
- Promoter holding
- 28.85%+0.00% QoQ
- FII holding
- 0.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthy Life Agritec Ltd
All →Healthy Life Agritec Board Meeting Date
Healthy Life Agritec will meet on 14 November 2026 to consider unaudited quarterly results for September 2026. Trading window closes from 1 October 2026.
Healthy Life Agritec Other Announcement
Healthy Life Agritec Ltd submitted the compliance certificate under SEBI Regulation 74(5) for the quarter ended 30th September 2026.
Healthy Life Agritec Board Meeting Date
Healthy Life Agritec has postponed its Board Meeting scheduled for September 29, 2026, due to pending in-principle approval from the Stock Exchange regarding its Rights Issue.
Healthy Life Agritec Annual General Meeting
Healthy Life Agritec Ltd held its 7th Annual General Meeting on 26th September 2026 to transact business, including adoption of financial statements and related party transactions.
Healthy Life Agritec Fund Raise of ₹50 Cr
Healthy Life Agritec's Board approved a rights issue of partly paid-up equity shares up to ₹50 Crore. Issue price and record date to be determined later.
- Value
- ₹50.00 Cr
Healthy Life Agritec Board Meeting Date
Healthy Life Agritec Limited scheduled a board meeting for September 23, 2026, to discuss a proposal for raising funds through equity or other securities.
Other regulatory approval announcements
All →Sandur Manganese & Iron Ores Regulatory Approval
Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.
- iron ore RoM capacity
- 9.42 MTPA
Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Arihant Capital Markets Regulatory Approval
Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.
Dr. Reddy's Laboratories Regulatory Approval
Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.
Emmbi Industries Regulatory Approval
SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.